Observational Study: Changes in Reflux Symptoms and Reflux Finding Score According to Rabeprazole Treatment Period.
Phase of Trial: Phase IV
Latest Information Update: 16 Jun 2014
At a glance
- Drugs Rabeprazole (Primary)
- Indications Laryngopharyngeal reflux; Peptic ulcer
- Focus Therapeutic Use
- Sponsors Janssen
- 29 Jan 2009 Planned number of patients changed from 996 to 1142 as reported by ClinicalTrials.gov.
- 29 Jan 2009 Actual end date (Apr 2008) added as reported by ClinicalTrials.gov.
- 29 Jan 2009 Actual initiation date (Sep 2007) added as reported by ClinicalTrials.gov.